Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2003 Aug 05;10016:9578-83. doi: 10.1073/pnas.1133382100.
Show Gene links
Show Anatomy links
Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2.
Marcora E
,
Gowan K
,
Lee JE
.
???displayArticle.abstract???
NeuroD (ND) is a basic helix-loop-helix transcription factor important for neuronal development and survival. By using a yeast two-hybrid screen, we identified two proteins that interact with ND, huntingtin-associated protein 1 (HAP1) and mixed-lineage kinase 2 (MLK2), both of which are known to interact with huntingtin (Htt). Htt is a ubiquitous protein important for neuronal transcription, development, and survival, and loss of its function has been implicated in the pathogenesis of Huntington's disease, a neurodegenerative disorder. However, the mechanism by which Htt exerts its neuron-specific function at the molecular level is unknown. Here we report that Htt interacts with ND via HAP1, and that MLK2 phosphorylates and stimulates the activity of ND. Furthermore, we show that Htt and HAP1 facilitate the activation of ND by MLK2. To our knowledge, ND is the first example of a neuron-specific transcription factor involved in neuronal development and survival whose activity is modulated by Htt. We propose that Htt, together with HAP1, may function as a scaffold for the activation of ND by MLK2.
Fig. 4. Htt, HAP1, and MLK2 activate ND. (A) Xenopus embryos were injected in one blastomere at the two-cell stage with various combinations of mRNA as indicated. Formation of ectopic neurons induced by ND was visualized as dark staining at the tail-bud stage by whole-mount immunostaining with an antibody against the neuronal marker N-CAM. A limiting amount of ND mRNA was used to elicit a minimal neurogenic response when injected alone (indicated by the arrow, Left Center). Results shown are representative of at least three independent experiments. (B) Quantitation of ectopic neurogenesis induced by ND. Bar graph shows mean percent of Xenopus embryos with ectopic neurons ± SEM of at least three independent experiments performed as described above. Dark areas show mean percent of Xenopus embryos with extensive and intense ectopic neurogenesis.
Andrade,
HEAT repeats in the Huntington's disease protein.
1995, Pubmed
Andrade,
HEAT repeats in the Huntington's disease protein.
1995,
Pubmed
Balak,
Neural cell adhesion molecule expression in Xenopus embryos.
1987,
Pubmed
,
Xenbase
Cattaneo,
Loss of normal huntingtin function: new developments in Huntington's disease research.
2001,
Pubmed
Cattaneo,
Dysfunction of wild-type huntingtin in Huntington disease.
2003,
Pubmed
Chan,
Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior.
2002,
Pubmed
Dragatsis,
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.
2000,
Pubmed
Dunah,
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
2002,
Pubmed
Dyer,
Mutant protein in Huntington disease is resistant to proteolysis in affected brain.
2001,
Pubmed
Gallo,
Mixed-lineage kinase control of JNK and p38 MAPK pathways.
2002,
Pubmed
Kholodenko,
MAP kinase cascade signaling and endocytic trafficking: a marriage of convenience?
2002,
Pubmed
Kim,
NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development.
2001,
Pubmed
Kim,
Transactivation of the mouse sulfonylurea receptor I gene by BETA2/NeuroD.
2002,
Pubmed
La Spada,
Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
2001,
Pubmed
Leavitt,
Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo.
2001,
Pubmed
Lee,
Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein.
1995,
Pubmed
,
Xenbase
Lee,
JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors.
2002,
Pubmed
Leung,
Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3.
1998,
Pubmed
Li,
A huntingtin-associated protein enriched in brain with implications for pathology.
1995,
Pubmed
Li,
Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking.
2002,
Pubmed
Liu,
Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin.
2000,
Pubmed
Liu,
Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems.
2000,
Pubmed
Luthi-Carter,
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.
2002,
Pubmed
Malecki,
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus.
1999,
Pubmed
Miyata,
NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus.
1999,
Pubmed
Moore,
Posttranslational mechanisms control the timing of bHLH function and regulate retinal cell fate.
2002,
Pubmed
,
Xenbase
NULL,
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
1993,
Pubmed
Nagata,
The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3.
1998,
Pubmed
Nasir,
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.
1995,
Pubmed
Naya,
Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor.
1995,
Pubmed
Naya,
Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice.
1997,
Pubmed
Nucifora,
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
2001,
Pubmed
O'Kusky,
Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene.
1999,
Pubmed
O'Shea,
Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.
2002,
Pubmed
Olson,
NeuroD2 is necessary for development and survival of central nervous system neurons.
2001,
Pubmed
Orr,
Qs in the nucleus.
2001,
Pubmed
Pennesi,
BETA2/NeuroD1 null mice: a new model for transcription factor-dependent photoreceptor degeneration.
2003,
Pubmed
Petersen,
Glucose induced MAPK signalling influences NeuroD1-mediated activation and nuclear localization.
2002,
Pubmed
Phelan,
Activated JNK phosphorylates the c-terminal domain of MLK2 that is required for MLK2-induced apoptosis.
2001,
Pubmed
Poulin,
NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene.
1997,
Pubmed
Ross,
Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.
2002,
Pubmed
Saudou,
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.
1998,
Pubmed
Sharrocks,
Docking domains and substrate-specificity determination for MAP kinases.
2000,
Pubmed
Sipione,
Modeling Huntington's disease in cells, flies, and mice.
2001,
Pubmed
Smith,
Signaling complexes: junctions on the intracellular information super highway.
2002,
Pubmed
Sorkin,
Signal transduction and endocytosis: close encounters of many kinds.
2002,
Pubmed
Takano,
The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor.
2002,
Pubmed
Turner,
Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate.
1994,
Pubmed
,
Xenbase
Velier,
Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways.
1998,
Pubmed
Verhey,
Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules.
2001,
Pubmed
Watada,
Distinct gene expression programs function in progenitor and mature islet cells.
2003,
Pubmed
White,
Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.
1997,
Pubmed
Whitmarsh,
A mammalian scaffold complex that selectively mediates MAP kinase activation.
1998,
Pubmed
Zuccato,
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
2001,
Pubmed
